AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 290: H813-H822, 2006. First published September 19, 2005; doi:10.1152/ajpheart.00543.2005
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/2/H813    most recent
00543.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hosaka, K.
Right arrow Articles by van Helden, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hosaka, K.
Right arrow Articles by van Helden, D. F.

Calcitonin gene-related peptide activates different signaling pathways in mesenteric lymphatics of guinea pigs

Kayoko Hosaka,1 Sharyn E. Rayner,1 Pierre-Yves von der Weid,2 Jun Zhao,1 Mohammad S. Imtiaz,1 and Dirk F. van Helden1

1Neuroscience Group, School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, New South Wales, Australia; and 2Mucosal Inflammation Research Group and Smooth Muscle Research Group, Department of Physiology and Biophysics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada

Submitted 23 May 2005 ; accepted in final form 11 September 2005

The effects of calcitonin gene-related peptide (CGRP) on constriction frequency, smooth muscle membrane potential (Vm), and endothelial Vm of guinea pig mesenteric lymphatics were examined in vitro. CGRP (1–100 nM) caused an endothelium-dependent decrease in the constriction frequency of perfused lymphatic vessels. The endothelium-dependent CGRP response was abolished by the CGRP-1 receptor antagonist CGRP-(8–37) (1 µM) and pertussis toxin (100 ng/ml). This action of CGRP was also blocked by the nitric oxide (NO) synthase inhibitor NG-nitro-L-arginine (L-NNA; 10 µM), an action that was reversed by the addition of L-arginine (100 µM). cGMP, adenylate cyclase, cAMP-dependent protein kinase (PKA), and ATP-sensitive K+ (KATP+) channels were all implicated in the endothelium-dependent CGRP response because it was abolished by methylene blue (20 µM), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (10 µM), dideoxyadenosine (10 µM), N-[2-(p-bromociannamylamino)-ethyl]-5-isoquinolinesulfonamide-dichloride (H89; 1 µM) and glibenclamide (10 µM). CGRP (100 nM), unlike acetylcholine, did not alter endothelial intracellular Ca2+ concentration or Vm. CGRP (100 nM) hyperpolarized the smooth muscle Vm, an effect inhibited by L-NNA, H89, or glibenclamide. CGRP (500 nM) also caused a decrease in constriction frequency. However, this was no longer blocked by CGRP-(8–37). CGRP (500 nM) also caused smooth muscle hyperpolarization, an action that was now not blocked by L-NNA (100 µM). It was most likely mediated by the activation of the cAMP/PKA pathway and the opening of KATP+ channels because it was abolished by H89 or glibenclamide. We conclude that CGRP, at low to moderate concentrations (i.e., 1–100 nM), decreases lymphatic constriction frequency primarily by the stimulation of CGRP-1 receptors coupled to pertussis toxin-sensitive G proteins and the release of NO from the endothelium or enhancement of the actions of endogenous NO. At high concentrations (i.e., 500 nM), CGRP also directly activates the smooth muscle independent of NO. Both mechanisms of activation ultimately cause the PKA-mediated opening of KATP+ channels and resultant hyperpolarization.

smooth muscle; endothelium; nitric oxide; adenosine 3',5'-cyclic monophosphate-dependent protein kinase; vasomotion



Address for reprint requests and other correspondence: D. F. van Helden, School of Biomedical Sciences, Faculty of Health, Univ. of Newcastle, Callaghan, NSW 2308, Australia (e-mail: dirk.vanhelden{at}newcastle.edu.au)




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. J. Dougherty, M. J. Davis, D. C. Zawieja, and M. Muthuchamy
Calcium sensitivity and cooperativity of permeabilized rat mesenteric lymphatics
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1524 - R1532.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.